2004-07-01
Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings
Publication
Publication
The American Journal of Cardiology , Volume 94 - Issue 1 p. 115- 118
The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.
| Additional Metadata | |
|---|---|
| doi.org/10.1016/j.amjcard.2004.03.040, hdl.handle.net/1765/57443 | |
| The American Journal of Cardiology | |
| Organisation | Department of Cardiology |
|
Tanabe, K., Hoye, A., Lemos Neto, P., Aoki, J., Arampatzis, C., Saia, F., … Serruys, P. (2004). Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. The American Journal of Cardiology, 94(1), 115–118. doi:10.1016/j.amjcard.2004.03.040 |
|